Position in BMY
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$923,849,108
-$16,832,324 QoQ
Shares Held
16,033,480
+3.4% QoQ
Ownership
0.785%
of shares outstanding
% of Portfolio
0.07%
of 13F equity value
Holder Rank
#24
of 2,514 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 94%
None 6%
Common Shares in BMY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Invesco Ltd. holds $27,851,957,097 across 16 Drug Manufacturers - General names. BMY ranks #8 (3.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | AMGN |
Amgen Inc
|
16,320,446 | $5,909,959,895 | |
| 2 | GILD |
Gilead Sciences, Inc.
|
39,819,151 | $5,030,751,525 | |
| 3 | LLY |
ELI LILLY & Co
|
3,694,152 | $4,430,877,092 | |
| 4 | JNJ |
Johnson & Johnson
|
15,674,093 | $3,980,749,389 | |
| 5 | MRK |
Merck & Co., Inc.
|
18,611,171 | $2,391,535,466 | |
| 6 | AZN |
Astrazeneca PLC
|
10,177,013 | $1,929,765,193 | |
| 7 | ABBV |
AbbVie Inc.
|
7,114,782 | $1,790,363,732 | |
| 8 | BMY |
Bristol Myers Squibb Co
This page
|
16,033,480 | $923,849,108 |
All Filings in BMY
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $923,849,108 | 16,033,480 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $940,681,432 | 15,509,999 | Shares | Defined | 2026-05-12 | |
| 2025-12-31 | $907,944,124 | 16,832,483 | Shares | Defined | 2026-02-19 | |
| 2025-09-30 | $794,936,198 | 17,626,080 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $847,823,236 | 18,315,473 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $1,065,077,874 | 17,463,156 | Shares | Defined | 2025-05-12 | |
| 2024-12-31 | $929,698,766 | 16,437,390 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $837,939,843 | 16,195,204 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $607,649,382 | 14,631,577 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $914,049,785 | 16,855,058 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $800,540,199 | 15,602,031 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $905,806,298 | 15,606,587 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $918,685,547 | 14,365,685 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $1,021,307,304 | 14,735,353 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $1,080,933,546 | 15,023,399 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $1,332,742,489 | 18,747,257 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $1,345,711,444 | 17,476,772 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $1,234,074,513 | 16,898,186 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $1,077,837,707 | 17,286,892 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $930,808,704 | 15,731,092 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $1,029,020,439 | 15,399,887 | Shares | Defined | 2021-08-17 | |
| 2021-03-31 | $1,073,726,776 | 17,008,186 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $1,159,049,831 | 18,685,311 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $1,278,625,606 | 21,207,922 | Shares | Defined | 2020-11-16 | |
| 2020-06-30 | $1,349,155,997 | 22,944,830 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $1,260,856,065 | 22,620,310 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||